These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4869985)

  • 1. Use of anti-lymphocyte serum to prolong renal allograft survival in dogs.
    Fujimoto Y; Miura T; Uchida H; Inou T
    Jpn J Exp Med; 1967 Jun; 37(3):205-16. PubMed ID: 4869985
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged survival of renal allografts in dogs treated with anti-lymphocyte serum.
    Abbott WM; Otherson HB; Monaco AP; Simmons RL; Russell PS; Wood ML
    Surg Forum; 1966; 17():228-30. PubMed ID: 5331809
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of antithymocyte serum in the treatment of canine renal homografts.
    Braf ZF; Smellie WA; Williams GM; Hume DM
    Surg Gynecol Obstet; 1969 Jul; 129(1):71-8. PubMed ID: 4892857
    [No Abstract]   [Full Text] [Related]  

  • 4. Histologic and histochemical studies of canine renal allografts. Untreated and treated with imuran or lymphocyte antiserum.
    Kirchheim D; Braun E; Niles NR
    Invest Urol; 1967 Mar; 4(5):463-74. PubMed ID: 5335748
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation of an effective heterologous anti-lymphocyte serum for use in the dog.
    Atai M; Kelly WD
    Surg Forum; 1966; 17():249-51. PubMed ID: 5331815
    [No Abstract]   [Full Text] [Related]  

  • 6. [The immunosuppressive effect of a heterologous dog antilymphocytic serum].
    Pichlmayr R; Brendel W; Pichlmayr I
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(3):313-9. PubMed ID: 4969335
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of anti-lymphocyte serum on the survival of the allogenic renal graft in the dog].
    Otte H; Grosjean O
    C R Seances Soc Biol Fil; 1967 Sep; 161(3):738-40. PubMed ID: 4229425
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of canine renal allograft survival with antilymphoid antisera.
    Shanfield I; Ladaga LG; Wren SF; Blennerhassett JB; MacLean LD
    Surg Gynecol Obstet; 1968 Jul; 127(1):29-40. PubMed ID: 4872534
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney homotransplantation with special reference to cytotoxic antibody response.
    Yamada T; Kay JH
    Surgery; 1968 Apr; 63(4):637-45. PubMed ID: 4171414
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of survival of canine kidney allografts with antilymphocyteserum.
    Atai M; Kelly WD
    Surg Gynecol Obstet; 1967 Jul; 125(1):13-8. PubMed ID: 5338310
    [No Abstract]   [Full Text] [Related]  

  • 11. Antilymphocyte globulin pretreatment combined with azathioprine in the prolongation of dog renal allografts.
    Alexander JL; Macdonald AS; Kay RE; Busch GJ; Monteiro da Cunha JE; Birtch AG; Murray JE
    Surg Forum; 1968; 19():188-90. PubMed ID: 4180621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Horse anti-dog-lymphocyte serum].
    Dormont J; Eyquem A; Lavergne M; Bach JF; Dimitriu D; Watchi JM; Lamy R; Raynaud M
    Prog Immunobiol Stand; 1970; 4():230-8. PubMed ID: 4921387
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-lymphocyte serum in prolongation of dog renal homografts.
    Lwason RK; Ellis LR; Hodges CV
    Surg Forum; 1966; 17():515-6. PubMed ID: 5331836
    [No Abstract]   [Full Text] [Related]  

  • 14. Organ transplantation-today and tomorrow.
    Cohen SL
    Chic Med Sch Q; 1969; 28(1):33-43. PubMed ID: 4887683
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of canine renal allografts by horse anti-dog lymphocyte serum and globulin.
    Diethelm AG; Busch GJ; Dubernard JM; Orr WM; Glassock RJ; Birtch AG; Murray JE
    Ann Surg; 1969 Apr; 169(4):569-77. PubMed ID: 4886852
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present status of anti-lymphocyte serum and its problems].
    Fujimoto Y
    Geka Chiryo; 1969 Jul; 21(1):86-91. PubMed ID: 4901874
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental and clinical use of antilymphocytic serum in kidney transplantation.
    Zühlke V; Marchioro TL; Starzi TE
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; ():Suppl:469-76. PubMed ID: 4896594
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with heterologous anithymus sera: nephritis associated with modification of renal allograft rejection and the immune status of the host to the foreign protein.
    Guttmann RD; Carpenter CB; Lindquist RR; Merrill JP
    Transplantation; 1967 Jul; 5(4):Suppl:1115-20. PubMed ID: 4860605
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preparation, properties and activities of a horse anti-human lymphocyte serum].
    Traeger J; Carraz M; Fries D; Perrin J; Saubier E; Brochier J; Bernhardt JP; Archimbaud JP; Bonnet P; Veyssere C; Prevot R; Traeger-Fouillet Y; Bryon PA; Manuel Y
    Pathol Biol; 1968 Jan; 16(1):27-39. PubMed ID: 4869418
    [No Abstract]   [Full Text] [Related]  

  • 20. A histological technique for assaying the efficacy of methods designed to reduce allograft rejection.
    Stewart PA; Swinney J
    Br J Surg; 1972 Apr; 59(4):312. PubMed ID: 4553602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.